Steven M. Paul - Feb 16, 2022 Form 4 Insider Report for Karuna Therapeutics, Inc. (KRTX)

Role
President & CEO, Director
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
Stock symbol
KRTX
Transactions as of
Feb 16, 2022
Transactions value $
$0
Form type
4
Date filed
2/17/2022, 04:20 PM
Previous filing
Jan 5, 2022
Next filing
Apr 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (right to buy) Award $0 +147K $0.00 147K Feb 16, 2022 Common Stock 147K $111.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the options shall vest on February 16, 2023, and the remaining options shall vest in twelve equal three-month installments over the following three years, subject to continued service through such dates.